Lee J C, Tsai L C, Chang J G
Department of Forensic Science, Central Police College, Taiwan, Republic of China.
J Forensic Sci. 1995 Nov;40(6):1065-7.
An earlier study has shown that the three DQA1*4 alleles (0401, 0501 and 0601) can be distinguished by restriction enzyme digestion of the polymerase chain reaction (PCR) product derived from the DQ alpha AmpliType kit (Perikin-Elmer, Norwalk, NJ). We have found that the AmpliType PM kit (Perkin-Elmer, Branchburg, NJ) can also be used to achieve the same goal. In this case, a Bio-Profil image analysis system (Vilber Lourmat, Marne La Vallee, France) is used for evaluating the restricted patterns. After typing the six alleles of DQA1 by the AmpliType HLA DQ alpha Detection Reagent Set (Perkin-Elmer, Branchburg, NJ), the PCR products from the PM kit with allele 4 were digested with Fok I and RsaI, separately. Since the other five fragments from PM kit will conceal the digested fragments of the HLA DQA1 PCR products, we measured the optical density of the pre- and post-digested 242 bp fragments in Fok I digestion, and 214/221 bp fragments in Rsa I digestion to decide the results of enzyme digestion. Out of 136 samples used in this study, 61 contain the DQA1 allele 4 determined by the DQ alpha AmpliType method. All 61 were typed with enzyme digestion, of which there are 2.3%, 19.8% and 8.1% in allele 0401, 0501 and 0601, respectively. Our procedure can thus extend the utilization of AmpliType PM kit and increase the discrimination power of the DQA1 system, especially in populations with high distribution of allele 4.
一项较早的研究表明,通过对源自DQα扩增试剂盒(Perkin-Elmer,诺沃克,新泽西州)的聚合酶链反应(PCR)产物进行限制性酶切,可以区分三种DQA1*4等位基因(0401、0501和0601)。我们发现,AmpliType PM试剂盒(Perkin-Elmer,布兰奇堡,新泽西州)也可用于实现相同目的。在这种情况下,使用Bio-Profil图像分析系统(Vilber Lourmat,马恩河谷,法国)评估限制性图谱。使用AmpliType HLA DQα检测试剂套装(Perkin-Elmer,布兰奇堡,新泽西州)对DQA1的六个等位基因进行分型后,将来自PM试剂盒且带有等位基因4的PCR产物分别用Fok I和RsaI进行酶切。由于来自PM试剂盒的其他五个片段会掩盖HLA DQA1 PCR产物的酶切片段,因此我们测量了Fok I酶切中242 bp片段酶切前后的光密度,以及Rsa I酶切中214/221 bp片段酶切前后的光密度,以确定酶切结果。在本研究使用的136个样本中,有61个样本含有通过DQα扩增方法确定的DQA1等位基因4。所有61个样本均通过酶切进行分型,其中等位基因0401、0501和0601分别占2.3%、19.8%和8.1%。因此,我们的方法可以扩展AmpliType PM试剂盒的用途,并提高DQA1系统的鉴别能力,尤其是在等位基因4分布较高的人群中。